Pilot Study Describing the Early Evolution of the Sexual Function of Patients Receiving Adjuvant Hormone Therapy for Breast Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03395327|
Recruitment Status : Recruiting
First Posted : January 10, 2018
Last Update Posted : March 29, 2019
The 2014-2019 cancer plan emphasizes the need to "reduce the impact of cancer on personal life".
The impact of cancer on sexuality is multifactorial: fatigue, anxiety, impaired body image, chemotherapy treatment.
None of these studies specifically assessed the early impact on the quality of sexual life of patients.
The purpose of this study is to describe to describe the early evolution of the quality of sexual life of patients receiving adjuvant hormone therapy for breast cancer.
|Condition or disease||Intervention/treatment|
|Breast Cancer||Other: quality of life questionnaire|
|Study Type :||Observational|
|Estimated Enrollment :||50 participants|
|Official Title:||Pilot Study Describing the Early Evolution of the Sexual Function of Patients Receiving Adjuvant Hormone Therapy for Breast Cancer|
|Actual Study Start Date :||February 20, 2018|
|Estimated Primary Completion Date :||February 19, 2020|
|Estimated Study Completion Date :||May 15, 2020|
- Other: quality of life questionnaire
QLQ-C30 and BR23 (Quality of Life Questionnaire and Breast 23) Questionnaire FSFI (Female Sexual Function Index)
- score FSFI (Female Sexual Function Index) [ Time Frame: 3 month after adjuvant hormone therapy ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03395327
|Contact: Lucie AUZANNEAU||02 51 44 63 80 ext +email@example.com|
|La Roche-sur-Yon, France, 85925|
|Contact: Clotilde MORAND, PH firstname.lastname@example.org|
|Principal Investigator: Clotilde MORAND, PH|